Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan vs omeprazole vs no acid suppression for prevention of post-EVL ulcers in cirrhosis
TCTR20260917005Phase 3Recruiting
- Sponsor
- Gastroenterological Association of Thailand
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vonoprazan, omeprazole in post-endoscopic variceal ligation ulcer (PEBU), esophageal varices, Cirrhosis, sponsored by Gastroenterological Association of Thailand. Started Mar 2026; status: recruiting.
02
Drugs
vonoprazanomeprazole
03
Conditions
post-endoscopic variceal ligation ulcer (PEBU)esophageal varicesCirrhosis
Beyond the preview
Go deeper on TCTR20260917005.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260917005.